It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
Eisai Pharmaceuticals' Halaven, which treats metastatic (spreading) late-stage breast cancer, was approved by the United States Food and Drug Administration last month. However, the drug would not have reached the market without the Canterbury University scientists' 27 years of research,...